About Us Offices Careers Blogs & Podcasts
Practice Areas Sectors People Insights
Practice Areas Sectors People Insights
About Us Offices Careers Blogs & Podcasts
Home Sectors Life Sciences Personalized Medicine
See Life Sciences

Personalized Medicine

Foley’s Personalized Medicine attorneys counsel you on matters involving the development and IP protection of genetic testing procedures and mobile health care, payer coverage issues, and patient privacy protection, among many others.

Our clients operating in the personalized medicine space recognize the rewards in bringing new products to market, while acknowledging some of the uncertainties and risks involved as regulatory and policy issues remain unanswered. Foley’s Personalized Medicine attorneys offer experience in cross-disciplinary areas, including business and private equity, regulatory, privacy, reimbursement, health care, and IP to help you as you do business in this emerging space.

Foley's Personalized Medicine Bulletin provides insight on the latest developments on various related topics.

Contacts

View All People in Personalized Medicine

Related Services

Health Care Implications for Personalized Medicine Companies
The personalized medicine industry faces particular challenges associated with securing payer coverage and reimbursement.
Learn More
Joint Ventures and Other Business Considerations for Personalized Medicine Companies
Realizing the promise of personalized medicine requires collaboration between a number of industry stakeholders.
Learn More
Personalized Medicine FDA and Regulatory Issues
The FDA Regulatory members of our Personalized Medicine Practice counsel and advise you on drug, biologic, and medical device development as well as other regulatory matters subject to FDA jurisdiction.
Learn More
Personalized Medicine IP Strategies and Solutions
In an emerging field like personalized medicine, there are additional IP areas that you must address.
Learn More
Personalized Medicine Privacy, Security, and HIPAA Regulations
The accumulation and use of health information, including personal health information (PHI), is a significant and unavoidable part of personalized medicine.
Learn More

Insights

Konski Quoted on Myriad Patent Case
10 October 2014
Bloomberg BNA’s Patent, Trademark & Copyright Journal
Konski Quoted on Patent Office's Post-Myriad Guide
13 March 2014
FDA Week
Brinckerhoff Quoted on Mayo v. Prometheus
20 March 2012
Reuters
Foley Attorneys File Amicus Brief Related to ACLU v. Myriad
11 January 2010